title: [Major hypoproteinemia revealing enteritis caused by Yersinia enterolytica and cytomegalovirus at the onset of chronic lymphocytic leukemia].
abstract: We report the first case of probable protein-losing enteropathy revealing a cytomegalovirus/Yersinia enterolytica infection at the onset of a chronic lymphocytic leukaemia. Severe hypoprotidaemia, digestive tract yersiniosis, ulcerative and microgranulomatous enteritis with a large number of cytomegalic inclusions in mucosal cells, and incipient lymphoid proliferation were the most characteristic findings.
authors.affiliation: Service de Médecine Interne, Hôpital de La Timone, Marseille.
authors.forename: P
authors.initials: P
authors.lastname: Disdier
authors.forename: V
authors.initials: V
authors.lastname: Veit
authors.forename: G
authors.initials: G
authors.lastname: Bolla
authors.forename: M A
authors.initials: MA
authors.lastname: Chrestian
authors.forename: A
authors.initials: A
authors.lastname: Gérolami
authors.forename: J R
authors.initials: JR
authors.lastname: Harlé
authors.forename: J M
authors.initials: JM
authors.lastname: Bartoli
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
mesh_terms: D000368:Aged; D003131:Combined Modality Therapy; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000473:pathology / Q000601:surgery / Q000821:virology; D004751:Enteritis / Q000150:complications* / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D011504:Protein-Losing Enteropathies / Q000209:etiology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D015007:Yersinia / Q000302:isolation & purification; D015009:Yersinia Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination
vernacular_title: Hypoprotidémie majeure révélatrice d'une entérite à Yersinia enterolytica et cytomégalovirus à la phase initiale d'une leucémie lymphoïde chronique.